Specifications: Permanent – Full time
Salary: £27,500 per annum
Location: Remote/London (one day per week in London office)
Closing date:  07 June 2024

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, Chief Executive Office and Finance and Corporate Services.

Cochrane is looking for a Communications and Events Assistant to support the team with a focus on media monitoring, social media and events.  This is a new role within the Communications team and will support colleagues across the team. This is a broad, entry-level role suitable for someone with an interest in science communication and events. The role will involve creating and posting content for internal and external communications, overseeing media monitoring and providing support for our flagship events.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values:

Collaboration: Underpins everything we do, locally and globally.
Relevant: The right evidence at the right time in the right format.
Integrity: Independent and transparent.
Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally.
• A flexible work environment
• A comprehensive onboarding experiences.
• An environment where people feel welcome, heard, and included, regardless of their differences.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations, and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• For further information on the role and click “how to apply”.
• The deadline to receive your application is 07 June 2024.
• The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
• Read our Recruitment Privacy Statement

Friday, May 17, 2024 Category: Jobs

Friday, May 17, 2024

Intervencije na trudnicama, novim majkama i drugim primarnim skrbnicima za prevenciju zubnog karijesa kod male djece Sprječava li pružanje osnovne dentalne skrbi i/ili informacija o oralnom zdravlju trudnicama, novim majkama i primarnim skrbnicima zubni karijes kod male djece? Ključne poruke • Pružanje informacija trudnicama, majkama i skrbnicima o zdravoj prehrani djeteta i metodama hranjenja, poput dojenja, hranjenja na bočicu i uvođenja čvrste hrane, moglo bi blago smanjiti rizik nastanka zubnog karijesa kod male djece. • Potrebno je više istraživanja kako bi se razumjele koristi i štetni...

Title: Senior Managing Editor
Specifications: Permanent Fulltime
Salary: £52,000 per annum
Location: UK – Remote/Flexible
Closing date: 28 May 2024

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development,  Chief Executive Office and Finance and Corporate Services.

Reporting to the Executive Editor and working with members of the Editorial Production and Methods Directorate, the role holder will need to have good awareness of Cochrane guidance for different types of standard and complex systematic reviews (intervention, qualitative, diagnostic test accuracy, prognosis, rapid and overview), plan how they will need to be handled in their team, and work to ensure that deadlines are met. The role holder will also be required to ensure that pilots aimed at innovating the editorial process can be supported as needed.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values: Collaboration: Underpins everything we do, locally and globally. Relevant: The right evidence at the right time in the right format. Integrity: Independent and transparent. Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally
• A flexible work environment
• A comprehensive onboarding experiences
• An environment where people feel welcome, heard, and included, regardless of their differences

Cochrane welcomes applications from a wide range of perspectives, experiences, locations and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• For further information on the role and how to apply, please click here
• The deadline to receive your application is 28 May 2024
• The supporting statement should indicate why you are applying for the post, and how far you meet the requirements, using specific examples.
• Read our Recruitment Privacy Statement

Tuesday, May 14, 2024 Category: Jobs

Jesu li mjere koje su škole poduzele za suzbijanje pandemije bolesti COVID-19 učinkovite? Ključne poruke • Općenito, rezultati sugeriraju da niz školskih mjera za smanjenje širenja bolesti COVID-19 može smanjiti širenje bolesti, korištenje zdravstvenih ustanova i dane pohađanja škole koji bi inače bili izgubljeni zbog karantene. • Potrebno je više kvalitetnih istraživanja kako bi se razumjelo kako škole mogu sigurno ostati otvorene tijekom mogućih budućih pandemija. Koje su mjere poduzele škole tijekom pandemije COVID-19? Tijekom pandemije COVID-19 mnoga su društva uvela posebne mjere u...

Oralni dodaci vitamina A za prevenciju akutnih infekcija gornjih dišnih puteva u djece do sedam godina Dosadašnje spoznaje Akutne infekcije gornjih dišnih puteva najčešće su akutne zarazne bolesti u djece, posebice djece predškolske dobi. Vitamin A ima pozitivnu ulogu u imunosnom sustavu i može poboljšati obranu domaćina od infekcija. Istraživanja pokazuju da djeca s nedostatkom vitamina češće pate od infekcija dišnog trakta. Stoga smo procijenili ulogu suplementacije vitamina A u prevenciji akutnih infekcija gornjih dišnih puteva u djece predškolske dobi (do sedam godina). Pitanje sustavnog...

Friday, May 10, 2024

Friday, May 10, 2024

Je li magnezijev sulfat za žene s rizikom od prijevremenog poroda bolji od placeba za zaštitu mozga njihovih beba? Ključne poruke Magnezijev sulfat koji se daje ženama s rizikom od prijevremenog poroda radi zaštite mozga njihovih beba smanjuje cerebralnu paralizu i kombinirani ishod smrti ili cerebralne paralize kod njihove djece do dvije godine starosti, u usporedbi s placebom. Buduća istraživanja u ovom području trebala bi se usredotočiti na učinke liječenja: • na djeci dok su adolescenti i odrasli; i • za različite skupine žena s rizikom od prijevremenog poroda, te s različitim načinima...

Pomaže li zajedničko donošenje odluka ženama pri donošenju odluke oko toga hoće li ili neće sudjelovati u probiru za rak dojke? Ključne poruke Zajedničko donošenje odluka bi moglo pomoći ženama da se osjećaju manje nesigurno ili žalosno te pomoći sa spoznajama tijekom procesa donošenja odluke o probiru raka dojke. Međutim, važno je napomenuti da je naše razumijevanje kako to točno može utjecati na odluke žena o probiru nepotpuno. Što znači zajedničko donošenje odluke? Zajedničko donošenje odluka je postupak u kojem liječnik i pacijent rade zajedno kako bi odabrali najbolju skrb. Razgovaraju...

Cink u prevenciji i liječenju prehlade Ključne poruke - Moguće je malo ili nikakvo smanjenje rizika od razvoja prehlade s dodacima cinka u usporedbi s placebom. - Za ljude koji su već prehlađeni, može doći do smanjenja trajanja prehlade uz upotrebu dodataka cinka u usporedbi s placebom. - Vjerojatno postoji povećanje rizika od lakših nuspojava kada se cink koristi za liječenje prehlade. Što je prehlada? Prehlada je prvenstveno virusna infekcija gornjih dišnih puteva. Ne postoji specifična kombinacija simptoma koja definira prehladu, ali simptomi mogu uključivati ​​začepljenost nosa, kihanje,...

We are delighted to announce the appointment of Dr Susan Phillips as the new Chair of Cochrane. Susan is Adjunct Associate Professor in the Faculty of Health Sciences & Medicine at Bond University, Queensland, Australia. She has held leadership positions in the field of evidence-based medicine since 2001 when she joined the Australian federal government’s newly established National Institute of Clinical Studies (NICS).

Susan is renowned for her achievements in translating research evidence into clinical practice. Her wealth of experience, gained from senior management roles at NICS where she became Interim Executive Director after the institute’s merger with Australia’s National Health and Medical Research Council, and later Chief Executive Officer at Therapeutic Guidelines Ltd, are testament to this. Her contribution to research translation was recognised with an Australia Day Medallion in 2008.

Susan’s extensive Board experience encompasses roles in organisations ranging from the Guidelines-International-Network (G-I-N), where she served as an elected Trustee for three terms, including two years as Vice-Chair, to Therapeutic Guidelines, and Therapeutic Guidelines Foundation. Susan has also served as Chair of other charities and not for profit organisations, including Climate for Change. She has been a Graduate of the Australian Institute of Company Directors (GAICD) since 2015.

In accepting this appointment, Dr Susan Phillips said: “I am deeply honoured to take on the role of Chair, especially during such a critical time for Cochrane when the need for trusted evidence to guide decisions about best treatments is greater than ever.”

Commenting on the appointment, Dr Tamara Kredo, Chair of the Governance and Nominations Committee, said “I am delighted that Dr Susan Phillips has been appointed Chair of Cochrane's Governing Board. Sue brings a wealth of experience and leadership qualities at an exciting time as we implement our new organizational strategy. I am sure you will all join me in expressing sincere thanks to Jordi Pardo Pardo who has served as Interim Chair of the Governing Board since September 2023. His commitment, hard work and enthusiasm have served the organisation well”.

Jordi will remain on the Governing Board until his term comes to an end later on this year.

Susan will take up the position as Chair in July 2024.

Tuesday, May 7, 2024

Kakvi su učinci antibiotika na bol i oteklinu uzrokovanu upalom ili infekcijom korijena zuba kod odraslih? Ključne poruke – Jedna doza antibiotika vjerojatno malo ili nimalo ne utječe na bol i oteklinu ako se uzima prije liječenja korijenskog kanala. – Dokazi o učinku antibiotika koji se uzimaju nakon debridmana (postupak koji uključuje djelomično ili potpuno čišćenje unutrašnjosti korijenskog kanala) na bol ili oteklinu vrlo su nesigurni. – Niti jedno istraživanje nije ispitalo učinak samih antibiotika, bez liječenja zuba, za ova dva stanja koja su obično odgovorna za uzrok zubobolje. Kako...

Postoji li najbolji način za uklanjanje mrtvog tkiva s kirurških rana? Ključna poruka Ne možemo biti sigurni hoće li uklanjanje mrtvog ili zaraženog tkiva s kirurških rana ili njega koja se obično pruža utjecati na to koliko je vremena potrebno da se ukloni svo mrtvo tkivo iz rane i da rana zacijeli. Što smo htjeli saznati? Nakon kirurškog zahvata većina kirurških rana prirodno zacjeljuje bez komplikacija. Međutim, može doći do komplikacija kao što je infekcija, što može dovesti do odgođenog zacjeljivanja. Postoji mnogo različitih metoda uklanjanja mrtvog ili zaraženog tkiva (što se naziva...

Mogu li lijekovi poput vareniklina i citizina (parcijalni agonisti nikotinskih receptora) pomoći ljudima da prestanu pušiti i uzrokuju li neželjene učinke? Ključne poruke · Vareniklin može pomoći ljudima da prestanu pušiti najmanje 6 mjeseci. Dokazi pokazuju da djeluje bolje od bupropiona i uporabe samo jedne vrste nikotinske nadomjesne terapije (npr. samo flastera). Stope prestanka pušenja mogu biti slične uporabi više od jedne vrste nikotinske nadomjesne terapije u isto vrijeme (npr. flasteri i žvakaća guma zajedno). · Citizin može pomoći ljudima da prestanu pušiti najmanje 6 mjeseci....

Title: Legal Officer/Junior Legal Counsel
Specifications: Permanent – Part time (30 hours a week)
Salary: £38,000 per annum
Location: UK (Remote with occasional travel to the London office)
Closing date:  17 May 2024

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, Chief Executive Office and Finance and Corporate Services.

This role will sit within the Legal Team in Cochrane’s Finance & Corporate Services Directorate, which also includes the Finance and HR teams.

The Legal Officer/ Junior Legal Counsel will be required to support the Legal Counsel in providing legal advice to colleagues across the organisation, to enable Cochrane to manage risk and meet its legal and regulatory obligations. In addition to experience in contract law, the successful candidate will have excellent communication and organisational skills, a self-motivated and proactive approach to their work, and an enthusiasm for developing their knowledge and skills.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values:

• Collaboration: Underpins everything we do, locally and globally.
• Relevant: The right evidence at the right time in the right format.
• Integrity: Independent and transparent.
• Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally.
• A flexible work environment
• A comprehensive onboarding experiences.
• An environment where people feel welcome, heard, and included, regardless of their differences.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations, and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• Further information on the role and how to apply
• The deadline to receive your application is 17 May, 2024.
• The supporting statement should indicate why you are applying for the post and how far you meet the requirements, using specific examples. 
•        Read our Recruitment Privacy Statement

Friday, May 3, 2024 Category: Jobs

Title: Legal Counsel
Specifications: Permanent – Full time or part-time (4-5 days per week)
Salary: £59,000 per annum
Location: Remote working (UK office located in Central London)
Closing date:  17 May 2024

Cochrane is an international charity. For 30 years we have responded to the challenge of making vast amounts of research evidence useful for informing decisions about health. We do this by synthesising research findings and our work has been recognised as the international gold standard for high quality, trusted information.

Cochrane's strength is in its collaborative, global community. We have 110,000+ members and supporters around the world. Though we are spread out across the globe, our shared passion for health evidence unites us. Our Central Executive Team supports this work and is divided into five directorates: Evidence Production and Methods, Publishing and Technology, Development, Chief Executive Office and Finance and Corporate Services.

The Legal Counsel will be required to provide legal advice to colleagues across the organisation, to enable Cochrane to manage risk and meet its legal and regulatory obligations. The successful candidate will have excellent communication and organisational skills, a pragmatic approach, and the ability to prioritise and manage an unpredictable workload whilst paying close attention to detail.

The role will include line managing the Junior Legal Counsel, a role which we are also currently recruiting for.

Don’t have every single qualification? We know that some people are less likely to apply for a job unless they are a perfect match. At Cochrane, we’re not looking for “perfect matches.” We’re looking to welcome people to our diverse, inclusive, and passionate workplace. So, if you’re excited about this role but don’t have every single qualification, we encourage you to apply anyway. Whether it’s this role or another one, you may be just the right candidate.

Our organization is built on four core values:

Collaboration: Underpins everything we do, locally and globally.
Relevant: The right evidence at the right time in the right format.
Integrity: Independent and transparent.
Quality: Reviewing and improving what we do, maintaining rigour and trust.

You can expect:

• An opportunity to truly impact health globally.
• A flexible work environment
• A comprehensive onboarding experiences.
• An environment where people feel welcome, heard, and included, regardless of their differences.

Cochrane welcomes applications from a wide range of perspectives, experiences, locations, and backgrounds; diversity, equity and inclusion are key to our values.

How to apply

• Further information on the role and how to apply
• The deadline to receive your application is 17 May, 2024
• The supporting statement should indicate why you are applying for the post and how far you meet the requirements, using specific examples. 
• Read our Recruitment Privacy Statement

Friday, May 3, 2024 Category: Jobs

Thursday, May 2, 2024

Thursday, May 2, 2024

Smanjuje li cijepljenje trudnica protiv respiratornog sincicijskog virusa (RSV) hospitalizacije dojenčadi povezane s RSV-om? Ključne poruke • Istraživanja u ovom sustavnom pregledu ukazuju na to da cijepljenje protiv respiratornog sincicijskog virusa (RSV) tijekom trudnoće smanjuje hospitalizacije dojenčadi povezane s RSV-om. • Rezultati ukazuju na to da cijepljenje protiv RSV-a tijekom trudnoće ima mali ili nikakav učinak na rizik od urođenih mana u dojenčadi i vjerojatno ima mali ili nikakav učinak na rizik od ograničenja rasta fetusa. • Buduća istraživanja u ovom području trebala bi se...